Cadila gains on partnering with Takeda
Cadila Healthcare and Takeda Pharmaceutical Company (Takeda)
announced a partnership to tackle chikungunya, an emerging infectious disease.
The chikungunya virus is most often spread to people by Aedes aegypti and Aedes
albopictus mosquitoes, the same vectors that spread dengue and zika. The
broad-based agreement includes early stage development to the final
commercialisation of the vaccine. There is currently no vaccine to prevent or
medicine to treat chikungunya virus infection.
Tata Motors to launch new SUV “Hexa” in November
Tata Motors new SUV “Hexa” to be launched in November 2016;
positive
Tata Motors will launch its highly-anticipated SUV, Tata Hexa in
November this year. Hexa is designed by Tata's three design studios in India,
Italy and the UK. It has also taken its design inputs from Land Rover.
Dr Reddy’s launches generic version of Paricalcitol injection
Leading Pharma Company, Dr. Reddy’s Laboratories has announced
that it has launched Paricalcitol Injection, USP, in 2 mcg, 5 mcg, 10 mcg, a
therapeutic equivalent generic version of Zemplar® (paricalcitol) Injection in
the United States market approved by the US Food & Drug Administration
(USFDA).
Karur Vysya Bank board announces stock split
Shares of private sector lender Karur Vysya Bank rose nearly 2% to
Rs485.50, after its board approved the proposal for sub-division of existing
equity share.
The board of directors of the company at its meeting held on
September 19, 2016, has considered and approved the proposal for sub-division
of existing one equity share of Rs10 each face value fully paid up into 5
number of equity shares of Rs2 each face value subject to the approval of the
shareholders through postal ballot process.
Motherson Sumi raises Rs1993 cr via QIP issue
Auto component firm Motherson Sumi Systems has announced Rs1,
993.44 crore raising via issuance of 62,884,827 shares to qualified
institutional buyers.
The company in a regulatory filing said that qualified
institutional placement (QIP) issue opened on September eight and closed on
September 13 for receiving applications from investors.
CLICK HERE FOR GET DETAILS & JOIN OUR BEST ADVISORY - CAPITALSTARS
CALL US 0731-6790000 , 6669900
